NM_000435.3:c.3399C>A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000435.3(NOTCH3):​c.3399C>A​(p.His1133Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0161 in 1,613,984 control chromosomes in the GnomAD database, including 263 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 18 hom., cov: 33)
Exomes 𝑓: 0.017 ( 245 hom. )

Consequence

NOTCH3
NM_000435.3 missense

Scores

10
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.668
Variant links:
Genes affected
NOTCH3 (HGNC:7883): (notch receptor 3) This gene encodes the third discovered human homologue of the Drosophilia melanogaster type I membrane protein notch. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signalling pathway that plays a key role in neural development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remains to be determined. Mutations in NOTCH3 have been identified as the underlying cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). [provided by RefSeq, Jul 2008]
MIR6795 (HGNC:50031): (microRNA 6795) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01282531).
BP6
Variant 19-15179425-G-T is Benign according to our data. Variant chr19-15179425-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 256132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-15179425-G-T is described in Lovd as [Benign]. Variant chr19-15179425-G-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0118 (1793/152156) while in subpopulation NFE AF= 0.0204 (1385/67996). AF 95% confidence interval is 0.0195. There are 18 homozygotes in gnomad4. There are 811 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1793 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH3NM_000435.3 linkc.3399C>A p.His1133Gln missense_variant Exon 21 of 33 ENST00000263388.7 NP_000426.2 Q9UM47

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH3ENST00000263388.7 linkc.3399C>A p.His1133Gln missense_variant Exon 21 of 33 1 NM_000435.3 ENSP00000263388.1 Q9UM47

Frequencies

GnomAD3 genomes
AF:
0.0118
AC:
1793
AN:
152038
Hom.:
18
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00326
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00609
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.000388
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.0135
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0204
Gnomad OTH
AF:
0.00671
GnomAD3 exomes
AF:
0.0100
AC:
2514
AN:
251328
Hom.:
20
AF XY:
0.00980
AC XY:
1332
AN XY:
135868
show subpopulations
Gnomad AFR exome
AF:
0.00271
Gnomad AMR exome
AF:
0.00301
Gnomad ASJ exome
AF:
0.00496
Gnomad EAS exome
AF:
0.000163
Gnomad SAS exome
AF:
0.000686
Gnomad FIN exome
AF:
0.0134
Gnomad NFE exome
AF:
0.0171
Gnomad OTH exome
AF:
0.0104
GnomAD4 exome
AF:
0.0166
AC:
24195
AN:
1461828
Hom.:
245
Cov.:
36
AF XY:
0.0159
AC XY:
11549
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.00215
Gnomad4 AMR exome
AF:
0.00309
Gnomad4 ASJ exome
AF:
0.00482
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.000904
Gnomad4 FIN exome
AF:
0.0158
Gnomad4 NFE exome
AF:
0.0199
Gnomad4 OTH exome
AF:
0.0135
GnomAD4 genome
AF:
0.0118
AC:
1793
AN:
152156
Hom.:
18
Cov.:
33
AF XY:
0.0109
AC XY:
811
AN XY:
74390
show subpopulations
Gnomad4 AFR
AF:
0.00325
Gnomad4 AMR
AF:
0.00608
Gnomad4 ASJ
AF:
0.00432
Gnomad4 EAS
AF:
0.000389
Gnomad4 SAS
AF:
0.00124
Gnomad4 FIN
AF:
0.0135
Gnomad4 NFE
AF:
0.0204
Gnomad4 OTH
AF:
0.00664
Alfa
AF:
0.0154
Hom.:
38
Bravo
AF:
0.0102
TwinsUK
AF:
0.0189
AC:
70
ALSPAC
AF:
0.0239
AC:
92
ESP6500AA
AF:
0.00340
AC:
15
ESP6500EA
AF:
0.0181
AC:
156
ExAC
AF:
0.0102
AC:
1238
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0155
EpiControl
AF:
0.0141

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Nov 12, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

NOTCH3: BS1, BS2 -

Sep 10, 2024
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

See Variant Classification Assertion Criteria. -

not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 12, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Pulmonary arterial hypertension Benign:1
Sep 26, 2022
John Welsh Cardiovascular Diagnostic Laboratory, Baylor College of Medicine
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.38
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
3.9
DANN
Benign
0.95
DEOGEN2
Uncertain
0.57
D;D
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.30
N
LIST_S2
Uncertain
0.88
D;D
MetaRNN
Benign
0.013
T;T
MetaSVM
Uncertain
0.38
D
MutationAssessor
Uncertain
2.5
M;.
PrimateAI
Uncertain
0.56
T
PROVEAN
Uncertain
-2.4
N;.
REVEL
Uncertain
0.44
Sift
Uncertain
0.0010
D;.
Sift4G
Uncertain
0.0020
D;D
Polyphen
0.29
B;.
Vest4
0.45
MutPred
0.74
Gain of disorder (P = 0.0349);.;
MPC
0.97
ClinPred
0.077
T
GERP RS
-8.6
Varity_R
0.18
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs112197217; hg19: chr19-15290236; API